相似文献
1
Hyperglycemia as an effect of cardiopulmonary bypass: intra-operative glucose management.
J Extra Corpor Technol. 2006 Jun;38(2):168-73.
2
Safety and efficacy of intensive intraoperative glycaemic control in cardiopulmonary bypass surgery: a randomised trial.
Acta Anaesthesiol Scand. 2014 May;58(5):588-96. doi: 10.1111/aas.12305. Epub 2014 Mar 17.
3
Implementation of an intraoperative glycemic control protocol for cardiac surgery in a high-acuity academic medical center: an observational study.
J Clin Anesth. 2013 Mar;25(2):121-8. doi: 10.1016/j.jclinane.2012.06.019. Epub 2013 Jan 16.
4
The effect of combined preinduction thoracic epidural anaesthesia and glucocorticoid administration on perioperative interleukin-10 levels and hyperglycemia. A randomized controlled trial.
J Cardiovasc Surg (Torino). 2008 Feb;49(1):87-93.
5
Is hyperglycemia seen in children during cardiopulmonary bypass a result of hyperoxia?
J Thorac Cardiovasc Surg. 2001 Oct;122(4):753-8. doi: 10.1067/mtc.2001.115702.
6
Intraoperative management of hyperglycemia in the cardiac surgical patient.
Semin Thorac Cardiovasc Surg. 2006 Winter;18(4):330-8. doi: 10.1053/j.semtcvs.2006.05.002.
7
Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery.
J Thorac Cardiovasc Surg. 2005 Oct;130(4):1144. doi: 10.1016/j.jtcvs.2005.05.049.
8
Metabolic Uncoupling Following Cardiopulmonary Bypass.
Congenit Heart Dis. 2015 Nov-Dec;10(6):E250-7. doi: 10.1111/chd.12285. Epub 2015 Jul 29.
9
Effects of peri-operative glucose levels on adverse outcomes in infants receiving open-heart surgery for congenital heart disease with cardiopulmonary bypass.
Perfusion. 2011 Mar;26(2):133-9. doi: 10.1177/0267659110389843. Epub 2010 Nov 15.
10
[Perioperative monitoring and control of hyperglycemia during deep hypothermic circulatory arrest].
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Jul;23(7):387-91.
引用本文的文献
1
A distributional reinforcement learning model for optimal glucose control after cardiac surgery.
NPJ Digit Med. 2025 May 27;8(1):313. doi: 10.1038/s41746-025-01709-9.
2
Microvascular Dysfunction Following Cardioplegic Arrest and Cardiopulmonary Bypass: Impacts of Diabetes and Hypertension.
Biomedicines. 2025 Feb 7;13(2):409. doi: 10.3390/biomedicines13020409.
3
Comparative Analysis of Metabolomic Responses in On-Pump and Off-Pump Coronary Artery Bypass Grafting.
Ann Thorac Cardiovasc Surg. 2024;30(1). doi: 10.5761/atcs.oa.24-00126.
4
Start Strong, Finish Strong: A Review of Prehabilitation in Cardiac Surgery.
Life (Basel). 2024 Jun 29;14(7):832. doi: 10.3390/life14070832.
5
Postoperative hyperglycemia among adult non-diabetic surgical patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
BMC Anesthesiol. 2024 Jul 1;24(1):217. doi: 10.1186/s12871-024-02592-9.
6
In Vitro Investigation of Insulin Dynamics During 4 Hours of Simulated Cardiopulmonary Bypass.
Anesth Analg. 2025 Aug 1;141(2):267-272. doi: 10.1213/ANE.0000000000007106. Epub 2024 Jun 11.
7
Using Pharmacokinetic Modeling and Electronic Health Record Data to Predict Clinical and Safety Outcomes after Methylprednisolone Exposure during Cardiopulmonary Bypass in Neonates.
Congenit Heart Dis. 2023;18(3):295-313. doi: 10.32604/chd.2023.026262. Epub 2023 Jun 9.
8
Effect of glycemic control and glucose fluctuation on in-hospital adverse outcomes after on-pump coronary artery bypass grafting in patients with diabetes: a retrospective study.
Diabetol Metab Syndr. 2023 Feb 14;15(1):20. doi: 10.1186/s13098-023-00984-4.
9
Comparison of glucose control by added liraglutide to only insulin infusion in diabetic patient undergoing cardiac surgery: A preliminary randomized-controlled trial.
Ann Card Anaesth. 2023 Jan-Mar;26(1):63-71. doi: 10.4103/aca.aca_214_20.
10
Risk factors and impact of postoperative hyperglycemia in nondiabetic patients after cardiac surgery: A prospective study.
Medicine (Baltimore). 2019 Jun;98(23):e15911. doi: 10.1097/MD.0000000000015911.
本文引用的文献
1
Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial.
J Thorac Cardiovasc Surg. 2006 Jan;131(1):34-42. doi: 10.1016/j.jtcvs.2005.05.057.
2
Hyperglycemia during cardiac surgery.
J Thorac Cardiovasc Surg. 2006 Jan;131(1):11-3. doi: 10.1016/j.jtcvs.2005.05.027.
3
Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery.
J Thorac Cardiovasc Surg. 2005 Oct;130(4):1144. doi: 10.1016/j.jtcvs.2005.05.049.
4
Implementing tight glucose control after coronary artery bypass surgery.
Ann Thorac Surg. 2005 Sep;80(3):902-9. doi: 10.1016/j.athoracsur.2005.03.105.
5
Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery.
Eur J Cardiothorac Surg. 2005 Sep;28(3):425-30. doi: 10.1016/j.ejcts.2005.05.025.
6
Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.
Curr Pharm Des. 2005;11(18):2279-99. doi: 10.2174/1381612054367300.
7
Myocardial substrate metabolism in the normal and failing heart.
Physiol Rev. 2005 Jul;85(3):1093-129. doi: 10.1152/physrev.00006.2004.
8
Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes.
J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S78-82. doi: 10.1681/asn.2004110961.
9
Glucose and insulin influences on heart and brain in cardiac surgery.
Semin Cardiothorac Vasc Anesth. 2005 Jun;9(2):173-8. doi: 10.1177/108925320500900213.
10
A prospective randomized study to evaluate stress response during beating-heart and conventional coronary revascularization.
Ann Thorac Surg. 2004 Aug;78(2):506-12; discussion 506-12. doi: 10.1016/S0003-4975(03)01360-2.
Zotero 插件